Highly focalised thermotherapy using a ferrimagnetic cement in the treatment of a melanoma mouse model by low temperature hyperthermia

International Journal of Hyperthermia

Volumn 29, Issue 2, 2013, Pages 121-132

  Portela, Ana ^a   Vasconcelos, Mário ^a   Fernandes, Maria Helena ^a   Garcia, Mónica ^a   Silva, António ^b   Gabriel, Joaquim ^b   Gartner, Fátima ^b   Amorim, Irina ^b   Cavalheiro, José ^c  

^a Portugal   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

Ferrimagnetic cement; High frequency magnetic field; Hyperthermia; Tumour

Indexed keywords

CASPASE 3; CEMENT; FERRIMAGNETIC CEMENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DEATH; CONTROLLED STUDY; DISEASE MODEL; FEMALE; HIGHLY FOCALISED THERMOTHERAPY; HISTOPATHOLOGY; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; MAGNETIC FIELD; MELANOMA; MOUSE; NONHUMAN; RADIOGRAPHY; SCANNING ELECTRON MICROSCOPY; TEMPERATURE MEASUREMENT;

EID: 84874056021     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.767478     Document Type: Article

References (54)

1. Lee CT, Mace T, Repasky EA. Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer? Int J Hyperthermia 2010;26:232-246.
2. Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia 2006;22:197-203.
3. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al. The cellular and the molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002;43:33-56.
4. Pappeti M, Herman I. Mechanism of normal and tumorderived angiogenesis. Am J Physiol Cell Physiol 2002; 282:c947-c970.
5. Sakaguchi Y, Stephens LC, Makino M, Kaneko T, Strebel FR, Danhauser LL, et al. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats. Cancer Res 1995;55:5459-5464.
6. Vaupel PW, Kelleher DK. Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: Heterogeneity is the key issue. Int J Hyperthermia 2010;26:211-223.
7. Jordan A, Scholz R, Wust P, Fahling H, Felix R. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999;201:413-419.
8. Sakuray H, Kitamoto Y, Saitoh J, Nonaka T, Ishikawa H, Kiyohara H, et al. Attenuation of chronic thermotolerance by KNK437, a benzylidene lactam compound, enhances thermal radiosensitization in mild temperature hyperthermia combined with low dose-rate irradiation. Int J Radiat Biol 2005;81:711-718.
9. Armour EP, McEachern D, Wang Z, Corry PM, Martinez A. Sensitivity of human cells to mild hyperthermia. Cancer Res 1993;53:2740-2744.
10. Mackey MA, Anolik SL, Roti Roti JL. Cellular mechanisms associated with the lack of chronic thermotolerance expression in HeLa S3 cells. Cancer Res 1992;52:1101-1106.
11. Ryu S, Brown SL, Kim SH, Khil MS, Kim JH. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996;34:133-138.
12. Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1996;12:367-373.
13. Kong G, Anyarambhatla G, Petros WP, Braun RD, Colvin OM, Needham D, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release. Cancer Res 2000;60:6950-6957.
14. Milani V, Noessner E, Ghose S, Kuppner M, Ahrens B, Scharner A, et al. Heat shock protein 70: Role in antigen presentation and immune stimulation. Int J Hyperthermia 2002;18:563-575.
15. O'Neill KL, Fairbairn DW, Smith MJ, Poe BS. Critical parameters influencing hyperthermia-induced apoptosis in human lymphoid cell lines. Apoptosis 1998;3:369-375.
16. Field SB. Physics and technology of hyperthermia. In: Field SB and Franconi C, editors. NATO ASI series, E: Applied Sciences. Dordrecht: Martinus Nijhoff; 1987. pp 19-27.
17. Szasz A. Hyperthermia, a modality in the wings. J Cancer Res Ther 2007;3:56-66.
18. Moroz P, Jones SK, Gray BN. Magnetically mediated hyperthermia: Current status and future directions. Int J Hyperthermia 2002;18:267-284.
19. van der Zee J. Heating the patient: A promising approach? Ann Oncol 2002;13:1173-1184.
20. Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008;24:251-261.
21. Jordan A, Wust P, Scholz R, Tesch B, Fähling H, Mitrovics T, et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia 1996;12:705-722.
22. Sato K, Watanabe Y, Horiuchi A, Yukumi S, Doi T, Yoshida M, et al. Feasibility of new heating method of hepatic parenchyma using a sintered MgFe2O4 needle under an alternating magnetic field. J Surg Res 2008;146:110-116.
23. Suzuki M, Shinkai M, Honda H, Kobayashi T. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 2003;13:129-135.
24. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferromagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 2009;25:499-511.
25. Jones SK, Winter JG. Experimental examination of a targeted hyperthermia system using inductively heated ferromagnetic microspheres in rabbit kidney. Phys Med Biol 2001;46: 385-398.
26. Kawashita M, Tanaka M, Kokubo T, Inoue Y, Yao T, Hamada S, et al. Preparation of ferrimagnetic microspheres for in situ hyperthermic treatment of cancer. Biomaterials 2005;26:2231-2238.
27. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993;9:51-68.
28. Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldofner N, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 2005;64:283-292.
29. Schneider S, Rusconi S. Magnetic selection of transiently transfected cells. Biotechniques 1996;21:876-880.
30. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: An in vivo study. Jpn J Cancer Res 1998;89:463-469.
31. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposome: In vitro study. Jpn J Cancer Res 1996;87:1179-1183.
32. Ohno T, Wakabayashi T, Takemura A, Yoshida J, Ito A, Shinkai M, et al. Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study. J Neurooncol 2002;56:233-239.
33. Saito H, Mitobe K, Ito A, Sugawara Y, Maruyama K, Minamiya Y, et al. Self-regulating hyperthermia induced using thermosensitive ferromagnetic material with low Curie temperature. Cancer Sci 2008;99:805-809.
34. Kokubo T. Bioactive glass ceramics: Properties and applications. Biomaterials 1991;12:155-163.
35. Matsumine A, Takegami K, Asanuma K, Matsubara T, Nakamura T, Uchida A, et al. A novel hyperthermia treatment for bone metastases using magnetic materials. Int J Clin Oncol 2011;16:101-108.
36. Jiang Y, Ou J, Zhang Z, Qin Q. Preparation of magnetic and bioactive calcium zinc iron silicon oxide composite for hyperthermia treatment of bone cancer and repair of bone defects. J Mater Sci Mater Med 2011;22:721-729.
37. Kawashita M, Kawamura K, Li Z. PMMA-based bone cements containing magnetite particles for the hyperthermia of cancer. Acta Biomaterialia 2010;6:3187-3192.
38. Portela A, Vasconcelos M, Branco R, Gartner F, Faria M, Cavalheiro J. An in vitro and in vivo investigation of the biological behaviour of a ferrimagnetic cement for highly focalised thermotherapy. J Mat Sci Mat Med 2010;1:2413-2423.
39. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: An in vivo study. Jpn J Cancer Res 1998;89:463-469.
40. Norma Portuguesa. Avaliação biológica dos dispositivos médicos, Parte 2: Requisitos para o bem estar dos animais [Biological evaluation of medical devices, Part 2: Animal Welfare Requirements]. 2000, NP EN ISO 10993-2.
41. Buhtoiarov IN, Lum HE, Berke G, Sondel PM, Rakhmilevich AL. Synergistic activation of macrophages via CD40 and TLR9 results in T cells independent anti-tumor effects. J Immunol 2006;176:308-318.
42. Bancroft JD, Gamble M. Theory and Practice of Histological Techniques, 6th edn. New York: Churchill Livingstone; 2007.
43. Tucker RD, Loening SA, Landas S, Paulus JA, Ren ZY, Park JB. The effect of interstitial hyperthermia on the Dunning prostate tumor model. J Urol 1992;147:1129-1133.
44. Dings RPM, Loren ML, Zhang Y, Mikkelson S, Mayo KH, Corry P, et al. Tumour thermotolerance, a physiological phenomenon involving vessels normalisation. Int J Hyperthermia 2011;27:42-52.
45. Cesta MF. Normal structure, function, and histology of the spleen. Toxicol Pathol 2006;34:455-465.
46. Balivada S, Rachakatla RS, Wang H, Samarakoon TN, Dani RK, Pyle M, et al. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: A mouse study. BMC Cancer 2010;10:119.
47. Ito A, Fujioka M, Yoshida T, Wakamatsu K, Ito S, Yamashita T, et al. 4-S-cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer Sci 2007;98:424-430.
48. Ito A, Saito H, Mitobe K, Minamiya Y, Takahashi N, Maruyama K, et al. Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature. Cancer Sci 2009;100:558-564.
49. Krysko D, Berghe TV, D'Herde K, Vandenabeele P. Apoptosis and necrosis: Detection, discrimination and phagocytosis. Methods 2008;44:205-221.
50. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
51. Green DR. Apoptotic pathways: Paper wraps stone blunts scissors. Cell 2000;102:1-4.
52. Garcia MP, Cavalheiro J, Fernandes MH. Acute and long-term effects of hyperthermia in B16-F10 melanoma cells. PLoS ONE 2012;7:e35489, doi:10.1371/journal.pone.0035489.
53. Ito A, Matsuoka F, Honda H, Kobayashi T. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Immunol Immunother 2004;53:26-32.
54. Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 2003;94:308-313.